GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM38292
Query DataSets for GSM38292
Status
Public on Dec 20, 2005
Title
Experiment 3: 3T3-F442A adipocytes. GH 30 min.
Sample type
RNA
Source name
3T3-F442A Adipocytes
Organism
Mus musculus
Extracted molecule
total RNA
Description
3T3-F442A adipocytes. GH 30 min.
Submission date
Jan 03, 2005
Last update date
Dec 21, 2005
Contact name
Jessica Schwartz
E-mail(s)
[email protected]
Phone
734-647-2124
Fax
734-647-9523
URL
http://www.umich.edu/~jschwrtz
Organization name
University of Michigan
Department
Molecular and Integrative Physiology
Street address
1301 Catherine St.
City
Ann Arbor
State/province
MI
ZIP/Postal code
48105-0622
Country
USA
Platform ID
GPL81
Series (1)
GSE2120
Growth Hormone (GH) Treatment of 3T3-F442A Adipocytes
Data table header descriptions
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-MurIL2_at
11.3
A
0.949771
AFFX-MurIL10_at
20.6
A
0.617401
AFFX-MurIL4_at
25
A
0.239063
AFFX-MurFAS_at
495.2
P
0.000195
AFFX-BioB-5_at
273.3
P
0.006187
AFFX-BioB-M_at
424.4
P
0.000195
AFFX-BioB-3_at
199.2
P
0.001248
AFFX-BioC-5_at
1292.6
P
0.00007
AFFX-BioC-3_at
965.1
P
0.000044
AFFX-BioDn-5_at
1644.6
P
0.000052
AFFX-BioDn-3_at
4174.3
P
0.000195
AFFX-CreX-5_at
16122.3
P
0.000044
AFFX-CreX-3_at
20364.9
P
0.000044
AFFX-BioB-5_st
18.8
A
0.382599
AFFX-BioB-M_st
57.7
A
0.574038
AFFX-BioB-3_st
22.5
A
0.749204
AFFX-BioC-5_st
16.2
A
0.891021
AFFX-BioC-3_st
6.6
A
0.772364
AFFX-BioDn-5_st
96.1
M
0.054213
AFFX-BioDn-3_st
50.6
A
0.078002
Total number of rows:
12488
Table truncated, full table size
320 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM38292.CEL.gz
2.8 Mb
(ftp)
(http)
CEL
GSM38292.EXP.gz
260 b
(ftp)
(http)
EXP
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|